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Abstract
Modifications of the Plasmodium falciparum–infected red blood cell (iRBC) surface have been linked to parasite-associated
pathology. Such modifications enable the parasite to establish long-lasting chronic infection by evading antibody mediate
immune recognition and splenic clearance. With the exception of the well-demonstrated roles of var-encoded PfEMP1 in
virulence and immune evasion, the biological significance of other variant surface antigens (rif and stevor) is largely unknown.
While PfEMP1 and RIFIN have been located on the iRBC surface, recent studies have located STEVOR at the iRBC membrane
where it may be exposed on the erythrocyte surface. To investigate the role of STEVOR in more detail, we have developed
antibodies against two putative STEVOR proteins and used a combination of indirect immunofluorescence assays (IFA), live
IFA, flow cytometry, as well as agglutination assays, which enable us to demonstrate that STEVOR is clonally variant at the
surface of schizont stage parasites. Crucially, expression of different STEVOR on the surface of the iRBC changes the antigenic
property of the parasite. Taken together, our data for the first time demonstrate that STEVOR plays a role in creating antigenic
diversity of schizont stage parasites, thereby adding additional complexity to the immunogenic properties of the iRBC.
Furthermore, it clearly demonstrates that to obtain a complete understanding of how parasite-induced pathology is linked to
variation on the surface of the iRBC, focusing the interactions of multiple multigene families needs to be considered.
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Introduction
During its maturation, the human malaria parasite Plasmodium
falciparum extensively modifies the surface of the infected Red
Blood Cell (iRBC). These modifications have been linked to
parasite associated pathology and are thought to enable the
parasite to evade antibody mediated immune recognition and
splenic clearance allowing the parasite to establish long lasting
chronic infection [1]. The var, rifin and stevor multigene family
coding for Plasmodium falciparum erythrocyte membrane protein 1
(PfEMP1), RIFIN and STEVOR respectively have been impli-
cated in these processes and have been postulated to play a role in
host-parasite interactions. PfEMP1 is expressed on the surface of
iRBCs [2,3] where it mediates the important pathogenic traits of
both clonal antigenic variation and the adhesion of iRBCs to a
variety of host receptors on the endothelium of the microvascu-
lature leading to the obstruction of blood vessels and contributing
to the pathology and disease severity seen with P. falciparum. More
recently, RIFINs have been shown to be clonally variant and to be
expressed on the iRBCs surface [4,5], although whether they are
involved in pathogenesis and antigenic variation has not yet been
established. Moreover, antibodies in hyper-immune sera from
adults recognize RIFIN proteins, indicating that these are
immunogenic, exposed, and induce malaria-specific IgG antibod-
ies [6,7]. Based on the high similarity in size and structure between
RIFIN and STEVOR proteins and their expression patterns in
parasite blood stages, these proteins are speculated to be involved
in antigenic variation [8,9].
stevor genes co-localized at the subtelomeric ends of the parasite’s
chromosomes along with the var and rif multigene families [10,11].
Transcription of var initiates early after red blood cell (rbc) invasion
followed by transcription of rifin and finally stevor [12,13].
Transcription of stevor in single parasite seems to be restricted to a
small number of genes (12), and there appears to be no coregulation
of transcription between the stevor and var gene families [14]. Stevor
and rifin show a similar two exon gene structure with a short exon I
encoding a signal peptide while the larger exon II codes for a
polypeptide possessing two predicted transmembrane domains
flanking a hypervariable region [1,15,16]. This structure of two
transmembrane domains flanking a hypervariable region appears to
be conserved among a number of gene families in P. falciparum [8]
and it has been proposed that the hypervariable region is exposed to
the host immune system at some stages during the infection.
Transport of parasite proteins to the surface of iRBC occurs via
Maurer’s clefts (MC) [17,18]. These organelles are believed to be
important in the assembly and transport of the cyto-adherence
complex of which PfEMP1 is a component to the RBC surface
[5,19–21]. While PfEMP1, RIFIN and STEVOR all can be
detected in MC at some stage during parasite development in the
RBC [12] only PfEMP1 and RIFIN have been unambiguously
shown to be located on the surface of the iRBC [4,5,22,23]. A
recent study has shown that epitope tagged STEVOR is exported
to the erythrocyte membrane [8] and this was subsequently
confirmed using STEVOR specific antibodies in both lab adapted
parasite lines as well as parasites directly obtained from patients
[24,25], supporting the hypothesis that it may be exposed on the
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and possibly play a role in antigenic variation. Consistent with
STEVOR playing a role in immune evasion is the observation that
the protein is not required for parasite survival in culture and
importantly that .90% of iRBC from recently isolated patient
samples express STEVOR compared to ,10% in long term
culture adapted parasites [25].
Despite these extensive efforts there is to date no data that
unambiguously demonstrates that STEVOR is indeed exposed on
the surface of the iRBC and thereby contributes to antigenic
variation. Importantlyno experimental evidenceon the validity of the
current two-transmembrane domain model is currently available
leaving a significant gap in our understanding on how STEVOR
mediates its function. In addition thef a c tt h a to n l yas m a l lp r o p o r t i o n
of the population of culture adapted parasites expresses STEVOR
makes it difficult to correlate transcriptional data obtained from this
culture to actual protein expression and highlights the importance of
linking transcription and expression data effectively. To address these
important questions in more detail, we established cloned parasite
lines that show uniform expression of STEVOR and developed
antibodies against two putative STEVOR proteins. Using a
combination of indirect immunofluorescence assays (IFA), live IFA,
flow cytometry analysis as well as agglutination assays we are able to
demonstrate that STEVOR is clonally variant at the surface of
schizont stage parasites. Moreover, variation in the expression of
STEVOR leads to changes in the immunogenic properties of the
surface of the iRBC. The data obtained here challenges the currently
predictedtwo-transmembranedomainstructureofSTEVOR.Taken
together, our data for the firsttime demonstrates that STEVOR plays
a role in creating antigenic diversity of schizont stage parasites,
thereby adding additional complexity to the immunogenic properties
of the iRBC.
Results
Variant expression of STEVOR in cultured parasites
Previous work had shown that while multiple stevor genes are
transcribed in long term cultured 3D7 parasites [12], in contrast
individual subclones obtained from the same population each
transcribed only one or a small number of stevor genes [9]. In
contrast, immunofluorescence microscopy using anti-STEVOR
antibodies clearly showed that only a small fraction of the culture
adapted parasites actually expressed STEVOR as compared to
parasites derived from patients where most parasites showed
STEVOR expression [25]. To establish whether it is possible to
obtain cloned parasites from 3D7 parasites that stably express a
single STEVOR variant; we first developed antibodies against the
semi-conserved N-terminal region of STEVOR (Figure 1A). Two
polyclonal sera S1 and S2 raised against two different STEVOR
(Figure 1B) were used to determine the expression levels of
STEVOR in four clones obtained by limiting dilution from 3D7
parasite culture (Figure 2). IFA of late stage parasites show that
clone 5A is recognized by both sera S1 and S2, while clones 3.2C
and 5.2A are recognized by anti-S1 and anti-S2 sera respectively
(Figure 2). Clone 5B is not recognized by either S1 or S2 antisera
(Figure 2) indicating that this parasite clone either does not express
STEVOR or expresses a variant that is not recognized by the two
anti-sera available.
Western blot of schizonts extracts prepared from the different
parasite clones confirmed the results obtained by IFA, with proteins
of the appropriate size (30–40 kDa) being detected by anti-S1 in
clones 5A and 3.2C (Figure 3A, upper left panel) and by anti-S2 in
clones 5A and 5.2A (Figure 3A, upper right panel). No protein could
be detected by either antisera in clone 5B confirming the IFA results
that this parasite does not appear to express STEVOR (Figure 3A).
Anti-glycophorin C serum recognizing a red blood cell membrane
protein band of 25 kDa was used as loading control. Recent work
[25] has shown that after sequential protein extraction STEVOR is
only detected in the membrane fraction in line with being an integral-
membrane protein. Consistent with this, both anti-S1 and S2
antibodies only detected the protein in the pellet fraction of the P.
falciparum parasite clones whileno STEVOR protein weredetected in
the supernatant and the carbonate-associated fractions (data not
shown). Careful comparison of the apparent molecular weight of the
STEVOR proteins detected by anti-S1 and anti-S2 indicated that
while anti-S1 detected a protein band of the apparent same size in
clones 5A and 3.2C there was a slight size difference in the protein
recognized in 5A and 5.2A (Figure 3A, lower panel) by anti-S2. This
would indicate that clones 5A and 5.2A express a different STEVOR
variant that is recognized by S2. This is in line with the previous
transcription studies indicating that cloned parasites stably transcribe
different stevor [9].
To establish whether the observed differences in STEVOR
expression are indeed linked to transcriptional changes in the
different parasite clones, microarray analysis was performed on
each clone. In line with previous studies [12,25], peak stevor
transcription was observed at 22–28 hours post invasion in clones
5.2A, 5A and 3.2C, with no stevor transcript being detected in clone
5B (Figure 3B and Table S1). Different stevor transcripts were
detected in the different clones with one stevor gene detected in
clone 5.2A (PFI0080w), three stevor (PF10_0395, PFA0090c, and
PFE0030c) detected in clone 3.2C and four stevor (PF10_0395,
PFA0090c, PFE0030c, and PF14_0767) being detected in clone
5A (Figure 3B). Previous studies using quantitative real time PCR
had obtained similar results using cloned parasites with one to a
few stevor transcript being detected in each cloned population [9].
The findings here are consistent with the western blot data where
clone 5.2A is only recognized by anti-S2, clone 3.2C only being
recognized by anti-S1 and clone 5A being recognized both by anti-
S1 and –S2. Combining the transcriptional and western blot data
it is highly likely that the STEVOR recognized by anti-S1 in
clones 5A and 3.2C is PF10_0395 and PFA0090c, while
Author Summary
Malaria remains a huge global health burden, infecting
hundreds of millions of people each year. Despite a
significant immune response by the host, the parasite can
establish long-lasting chronic infections. Parasite-induced
modifications on the surface of the infected red blood cell
(rbc) are linked to the ability of the parasite to evade host
immunity and may contribute to pathology. In the human
parasite Plasmodium falciparum, proteins encoded by two
parasite multigene families, called var and rif, have been
shown to be exposed on the surface of the rbc. How these
variant gene families help the parasite to evade the
immune response and contribute to disease severity is
important for the development of better antimalarial
treatment and intervention strategies. Here we show that
a third multigene family called stevor codes for proteins
that are expressed on the surface of the infected rbc. We
show that expression of different STEVOR changes the
antigenic properties of the infected rbc, indicating a
potential role of STEVOR in antigenic variation. These
findings provide important new insights about the
complexity of immune evasion by P. falciparum and in
the future may lead to a better understanding of how to
develop an efficient malaria vaccine.
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reactivity observed in clone 5A is most likely attributable to
PF14_0767, while PFE0030c is considered as pseudo-gene and
would not be expected to result in a functional protein.
To further validate the microarray results we further performed
quantitative RT-PCR analysis targeting the genes identified by the
microarray analysis in the four clones as well as PFF0850c
(STEVOR 2 (Figure 1B)). Using the previously validated primers
(Table S2) for the different stevor genes [9,14] as well as seryl-tRNA
synthetase (PF07_0073) as control gene [26] the transcription profile
of stevor was analyzed at mid-trophozoite stage (22–28 hours post
invasion) corresponding to the peak of total stevor transcript levels
[12]. The findings (Figure S1) support the microarray data with
the same transcription profile being detected in 5A and 3.2C
clones. One additional stevor transcript (PF14_0767 and PFF0850c)
was detected in the 5B and 5.2A clones respectively (Figure S1).
Taken together, these findings support the western blot and the
microarray analysis and are fully in line with previous transcrip-
tion studies [9,14] that have shown transcription of subset of stevor
in cloned 3D7 derived parasites.
STEVOR is located at the iRBC surface
In a recent study it has been shown that STEVOR does appear
to be trafficked beyond Maurer’s cleft and associate with the red
blood cell membrane [8,25]. A similar staining pattern is observed
when carrying out indirect immunofluorescence assay (IFA) using
anti-S1 and anti-S2 antisera and different stages of fixed iRBCs of
clones 5A, 3.2C and 5.2A shown to express STEVOR (Figure S2).
Figure 1. Schematic representation of STEVOR protein. (A) N-terminal signal sequences are shown in light grey, including a canonical signal
sequence (encoded by exon 1) and Plasmodium Exported Element/Vacuolar Transport Signal (PEXEL/VTS) sites. Predicted transmembrane domains
are shown in dark grey (TM1/TM2). Percentage amino acid similarity between the different regions of all available STEVOR sequences is taken from a
review by Kyes et al., [13]. (B) Schematic structure of stevor genes with intron spliced out. Location of signal peptide, predicted transmembrane
domains (TM1/TM2), conserved region (CR), and hypervariable region (HR) are indicated by amino acid (a.a) number. Orange arrows indicate primers
designed to clone the CR into pET41a (+) vector for generation of stevor antibodies.
doi:10.1371/journal.ppat.1000307.g001
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raised the question on whether STEVOR is exposed on the
surface. To address this, immunofluorescence staining of live
parasites was carried out using anti-S1 and -S2 antibodies and the
different STEVOR expressing clones. Both anti-S1 and anti-S2
antisera are able to stain the surface of live parasites (Figure 4A,
upper and middle rows and data not shown) with no staining
detected within the iRBC. This clearly contrasted to the IFA
results obtained with fixed parasites where staining could be
observed both in the MCs as well as the iRBC membrane (Figure
S2) and is consistent with surface location of STEVOR. Pre-
treatment of the iRBC with trypsin completely abolished the
labeling of the iRBC surface in life IFAs (Figure 4A, lower row and
data not shown) further supporting the surface location of
STEVOR. The MC specific antibody PfSBP1 did not stain iRBC
either in trypsin treated (data not shown) or untreated (Figure 4B,
upper row) samples. In contrast PfSBP1 stained iRBC efficiently in
this assay if the cells were permeabilized with Streptolysin O (SLO)
(Figure 4B, lower row) and similarly significant staining of internal
STEVOR with anti-S1 (or –S2) serum was observed following
SLO-permeabilization of the iRBC (Figure 4B, middle row).
Crucially, surface staining with anti-S1 and anti-S2 was only
observed in parasites clones that had previously been shown to be
recognized by these antibodies in IFA and Western blot analysis.
Surface location of STEVOR was further supported by life IFA
using antibody against the RBC membrane protein glycophorin C.
Life IFA co-staining of anti-S1 (Figure 5A (i), upper row) or anti-S2
(Figure 5A (i), lower row) with anti-glycophorin C clearly showed
the external location of both STEVOR and anti-glycophorin C.
No STEVOR staining could be detected in life IFA with 5B-
iRBCs using both anti-S1 and S2 antisera (Figure 5A (ii)).
To further confirm surface expression of STEVOR on the
iRBC, flow cytometry analysis (FACS) was performed with either
anti-S1 or S2 serum (Figure 5B). This clearly showed that
STEVOR is detected on the surface of the iRBC of the different
clones. Infected RBC of clones 5A and 3.2C were detected by anti-
S1 (Figure 5B, (ii) and (iii)) in this assay while clones 5A and 5.2A
reacted with anti-S2 (Figure 5B, (ii) and (iv)). No STEVOR
expression could be detected with either antisera in clone 5B
(Figure S3), nor did the iRBC alone or associated with the Alexa
Fluor Goat anti-rabbit secondary antibody alone, acting as a
negative control, stain the iRBC surface (Figure 5B, (i)). No
staining of iRBC was observed with the antibody targeting
PfSBP1, indicating that the observed STEVOR signal was not due
to leakiness of the iRBC (Figure S3). Interestingly, permeabiliza-
tion of the iRBC with SLO on the other hand now enabled
PfSBP1 to penetrate the iRBC and stain the cells in the FACS
analysis (Figure S3).
Late-stage parasites iRBC show increased STEVOR surface
expression
Previous studies have demonstrated that both PfEMP1 and
RIFIN appear at the surface of the iRBC during the trophozoite
stage [5,27], to assess the timing of STEVOR surface expression
FACS analysis using both anti-STEVOR sera was carried out on
different stages of parasite development using synchronous 5A
clone (Figure S3). No STEVOR expression could be detected in
ring stage parasites with some expression appearing during the
mid-trophozoite stage before peaking in late schizonts (Figure S3).
These findings are consistent with STEVOR gradually appearing
on the iRBC surface during late trophozoite and schizonts stage.
STEVOR-specific agglutination of iRBCs
Agglutination assays of iRBC provide a good sign for the ability
of antibodies or a particular serum to react with the surface
Figure 2. Selection of 3D7 clonal lines. Clonal lines from P. falciparum 3D7 parasites were isolated by limiting dilution as described in Materials
and Methods. Whole field immunofluorescences co-staining of anti-PfSBP1 with either anti-S1 (A) or anti-S2 (B) antisera are shown for the four
selected clones. Individual staining (dapi, anti-S1/S2, anti-SBP1) as well as merge images are shown for each clone.
doi:10.1371/journal.ppat.1000307.g002
Expression of STEVOR on Surface of Red Blood Cells
PLoS Pathogens | www.plospathogens.org 4 February 2009 | Volume 5 | Issue 2 | e1000307expressed parasite antigens [28]. The specific anti-STEVOR
antibodies were tested for their ability to bind and agglutinate
iRBC. Consistent with all the other data, anti-S1 antibody was
only able to agglutinate 5A and 3.2C (Figure 6A, (i) and (iii)) while
anti-S2 antibody agglutinates 5A and 5.2A (Figure 6A, (i) and (iv)).
The proportion of iRBCs in agglutinates varies across samples and
agglutinates up to 20 iRBCs were observed. A few uninfected
erythrocytes were observed in agglutinates with iRBCs and did not
agglutinate with other uninfected erythrocytes. These uninfected
erythrocytes can be considered as contaminations. Autoagglutina-
Figure 3. Transcription and expression analyses of STEVOR. (A) Immunoblotting of carbonate-insoluble pellet integral membrane proteins of
schizont extracts of clones 5A, 5B, 3.2C, and 5.2A. A protein band of approximately 35 kDa was detected by anti-S1 serum in clones 5A and 3.2C
(upper left panel) and by anti-S2 serum in clones 5A and 5.2A (upper right panel). Mouse anti-glycophorin C antibody recognizing a protein band of
25 kDa was used as loading control. Molecular weight comparison of detected STEVOR proteins by anti-S1 (lower left panel) and anti-S2 (lower right
panel) is also shown. Secondary anti-rabbit (or mouse) IgG horseradish peroxydase-conjugated antibodies (Bio-Rad) and West Pico
chemiluminescence (Pierce) were used to visualize the detected proteins in photographic film. Molecular marker (MM, Biorad) used for protein
size comparison is shown. (B) Microarray analysis of the expression profile of transcribed stevor genes at mid-trophozoite stage (22–28 hours post
invasion) of each clone. Level of transcription was determined in relation to a pool of RNA as described in Materials and Methods. Individual stevor
genes with regulated transcription are shown by their accession number.
doi:10.1371/journal.ppat.1000307.g003
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or more infected erythrocytes could be ruled out in our assay as
either pre-immune sera (Figure 6A, (v)), or 5B parasites (Figure 6A,
(ii)) did not show any agglutinates. Importantly, the P. falciparum
strain A4, previously shown to express RIFIN but not STEVOR
[5,25] did not react with the two antibodies (Figure S4). Trypsin
pre-treatment of the iRBC completely abolished the agglutination
phenotype (Figure 6A, (v)) further supporting the surface location
of STEVOR specific epitopes on the surface of the iRBC.
The percentage of cells in agglutinates and the size of the
agglutinates (Figure 6B) decreased with successive serum dilutions
indicating that the agglutination pattern reflects amount of
exposed antigens at the infected erythrocytes surface. Agglutinates
size and percentage of cells in agglutinates seen with both anti-S1
and –S2 in the parental 3D7 parasite were lower (Figure S4)
compared to those observed in 5A clonal line (agglutinated by
both S1 and S2 sera (Figure 6A, (i)), in 3.2C (Figure 6A, (iii)) and
5.2A (Figure 6A, (iv)) clones agglutinated by S1 and S2 sera
Figure 4. Location of native STEVOR at the iRBC surface. (A) Immunofluorescence assay of live 5A-infected erythrocytes with anti-S1 (upper
row) and anti-S2 (middle row) antisera recognizing native STEVOR at the iRBC surface. Either anti-S1 or anti-S2 (lower row) did not react with
trypsinized iRBC. The specific antibodies that reacted with the iRBC surface were detected with Alexa Fluor–labeled goat anti-rabbit IgG. Successive
columns from left to right denote bright field, parasite nucleus staining, specific antibody staining (shown in the right), and merge images. (B)
Immunofluorescence assay of live 5A-infected erythrocytes with anti-SBP1 (upper row) showing lack of staining of the iRBC. Middle and lower rows
showed, respectively, anti-S1 (or anti-S2) and anti-SBP1 staining after SLO-permeabilization of the infected RBC. The specific antibodies that reacted
with the iRBC surface were detected with Alexa Fluor–labeled goat anti-rabbit (or anti-mouse) IgG. The fluorescent images (individual stains and
merged) and the bright-field are shown. * denotes that the same staining pattern was observed with anti-S2 antibody.
doi:10.1371/journal.ppat.1000307.g004
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Glycophorin C antibodies. Panel (ii) illustrates lack of surface STEVOR staining of 5B-iRBCs with both anti-S1 (upper row) and –S2 (lower row). The
specific antibodies that reacted with the iRBC surface were detected with Alexa Fluor–labeled goat anti-rabbit (or anti-mouse) IgG. The fluorescent
images (individual stains and merged) and the bright-field are shown. (B) Flow cytometry assay to measure STEVOR antigens at the iRBC surface.
IRBCs alone or incubated with Alexa Fluor (AF) secondary antibody were used for controls (panel i). Live parasites of clones 5A (panel ii), 3.2C (panel
iii), and 5.2A (panel iv) were incubated with anti-S1 and anti-S2 antibodies followed by the Alexa Fluor secondary antibody. Percentage of STEVOR-
expressed iRBCs is shown as mean fluorescence in the upper left quadrant of each scatter plot, and Ethidium bromide–stained iRBCs appear in the
lower left quadrant.
doi:10.1371/journal.ppat.1000307.g005
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antibodies measured in the assays are clonally variant-specific
and consistent with data obtained by western blot and immuno-
fluorescence assay regarding the STEVOR expression of the
different clones.
Discussion
The expression of variant antigens on the surface of P. falciparum
infected red blood cells has been linked to immune evasion and
pathology. While the var, rifin and stevor multigene families are the
Figure 6. Parasites’ phenotypes in agglutination assays. (A) Typical positive agglutinates of 5A-infected erythrocytes with anti-S1 and anti-S2
(panel i) sera and 3.2C (panel iii) and 5.2A (panel iv)–infected erythrocytes with anti-S1 and anti-S2 sera, respectively. Neither anti-S1 nor anti-S2 serum
reacted with 5B (panel ii)–infected erythrocytes. Lack of reactivity was also observed with 5A-infected erythrocytes with pre-immune serum (panel v,
upper square) and with anti-S1/S2 serum after trypsin treatment of the iRBC (panel v, lower square). (B) Proportion of iRBCs in parasites agglutinated
by anti-S1 and/or anti-S2 sera. Size of the largest agglutinates decrease with increasing serum dilution. A, B, and C denote agglutinates with 3–5
iRBCs, 6–10 iRBCs, and .10 iRBCs, respectively.
doi:10.1371/journal.ppat.1000307.g006
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understanding of the role they play in parasite host interaction is
limited. Only for PfEMP1 has a functional role in adhesion to the
host endothelium via host specific receptors, the binding of
uninfected rbc to form rosettes, as well as antigenic variation been
demonstrated [16,22,29,30]. RIFIN are known to be located on
the surface of iRBC [5] and there is evidence that different RIFIN
are expressed in different parasite lines, leading to the postulation
that RIFIN play an additional role in antigenic variation [5,8]. In
addition RIFIN have also been proposed to play a role in rosette
formation though this needs to be confirmed. Recently, an
additional role in merozoite invasion or immune evasion has been
proposed for RIFIN based on the expression of a subset of RIFIN
in merozoites [31].
The role of STEVOR is even less clear. Its timing of expression
after both PfEMP1 and RIFIN indicated that it has a different
function [12] and this was supported by the initial observations
that unlike RIFIN and PfEMP1 the protein did not get trafficked
to the iRBC surface but remained inside MC [12,32]. Recent
studies showing that STEVOR moves out of the MC in late stage
parasite [8,24,25] and associates with rbc membrane have
challenged this idea. These studies though were unable to
unequivocally demonstrate that STEVOR is indeed presented at
the surface of the iRBC thereby being directly exposed to the host
immune system. Here for the first time we directly demonstrate
that STEVOR is expressed on the surface of the iRBC. We show
that STEVOR moves out of MC in late stage parasite and is
moved to the RBC surface where it is recognized by STEVOR
specific antibodies. The appearance of STEVOR on the surface is
after both PfEMP1 and RIFIN and would indicate that STEVOR
plays an important and distinct role in the later stage of the
parasite development in the RBC.
The extensive sequence diversity of different members of the
STEVOR family is in line with the protein being under selective
pressure by the immune system and our findings that the protein is
surface expressed is consistent with this. Interestingly, our data
contradict the predicted structure of STEVOR (Figure 1A) where
two transmembrane (TM) domains flank a surface exposed short
hypervariable region [10,15]. Rather our data clearly show that
the more semiconserved N-terminal region is exposed on the
surface. Based on the current model this would mean that the
hypervariable region is located on the inside of the RBC with the
N- and C-terminal parts of the protein being exposed. Our
alternative model is that the TM domain predicted between the N-
terminal and hypervariable region is not used and both regions are
therefore exposed on the surface of the iRBC being anchored to
the RBC membrane by the second C-terminal TM region. This
needs to be explored further but it highlights the importance of
validating predictions about the membrane topology of parasite
proteins.
We have previously been able to show that STEVOR is not
needed for survival of culture adapted parasites and this is seen by
the overall low expression of this protein in different parasite lines
[12,25]. This contrasts with expression of STEVOR in parasites
directly isolated from patients where transcription as well as
expression levels of STEVOR are much higher [25,33], indicating
an important role in the host. In this work we have now been able
to obtain parasite clones from the 3D7 strain that express different
members of STEVOR at high levels. This has enabled us to
unambiguously show surface location of STEVOR on the iRBC
but also for the first time provide a tool for studying the antigenic
diversity of STEVOR. While var gene switching leading to the
expression of different members of PfEMP1 on the surface of the
iRBC has been clearly demonstrated it has up to date been much
more difficult to link this to variation in immunogenic properties of
the iRBC [34]. Similarly, while antibodies recognizing RIFIN can
be found in natural infections it is again not clear how changes in
the RIFIN expression pattern impact on the recognition of the
iRBC. In our study we for the first time have generated antibodies
that can distinguish between different STEVOR proteins. These
antibodies have enabled us to convincingly demonstrate that
STEVOR is able to clonally vary on the surface of the iRBC and
importantly that these variations change the antigenic properties
of these cells. Based on these findings it is possible to conclude that
STEVOR plays a role in the antigenic variation of the late
developmental stages of the blood stage parasite.
Transcriptional analysis of stevor in clones derived from the
parasite strain NF54 show stable expression of a small number of
stevor genes over a significant period of time. How this correlated
with actual protein expression was not known. In our study we are
now able to show stable expression of a particular STEVOR
variant in single parasite clones over more then 30 generations. It
will be interesting to establish how quickly STEVOR expression
changes in the presence of an active immune response. At this
stage there is no evidence of a link between STEVOR antibodies
and clinical outcome, the fact that here now convincing evidence
showing surface expression and clonal antigenic variation of
STEVOR makes this now an important question to pursue.
In summary, we clearly show that STEVOR is located on the
surface of P. falciparum infected RBC. We furthermore show that
STEVOR expression is clonally variant and that expression of
different STEVOR variants changes the antigenic properties of
the iRBC. This strongly supports the role of STEVOR in
antigenic variation. Whether STEVOR mediates certain adhesive
functions in addition to immune evasion needs now to be
investigated. At this stage it is not clear why the malaria parasite
needs an additional variant antigen on the surface of the iRBC and
more studies are required to address this question.
Materials and Methods
Parasite culture
Well characterized P. falciparum laboratory parasites lines (3D7
and A4 clone (kind gift of Sue Kyes)) and clonal lines thereof, were
continuously cultured in fresh human RBCs in RPMI 1640
completed medium supplemented with 10% albumax as previ-
ously described [35]. If required, cultures with a parasitemia of
approximately 5% (mainly ring stage) were synchronized by
treatment with 5% (w/v) sorbitol as described [36,37]. Late stage-
schizont iRBCs were purified by treatment with 70% Percoll as
described by [38].
Tighter synchronization (Figure S3) was achieved by adding
purified schizont stage iRBC to fresh RBC for reinvasion. After
four hours the culture was treated with sorbitol to remove mature
stage parasites as previously described (38).
Bioinformatics
Sequence data, gene structure, predicted domains and protein
sequence for all stevor genes were obtained from PlasmodDB
(http://www.plasmodb.org/). NCBI BLAST (http://www.ncbi.
nlm.nih.gov/BLAST/) and ClustalW were used to check for
sequence alignment.
Generation of Stevor 1 and Stevor 2 antibodies
Two putative stevor genes (accession numbers: PF10_0395 and
PFF0850c) were used for generation of stevor antibodies.
Generation of stevor 1 antibody has been previously described
[25] and the same approach was used for generation of stevor 2
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the predicted signal sequence, transmembrane domains, semi-
conserved regions and hypervariable regions is represented
(Figure 1A and 1B).
Primers (Figure 1B) to conserved region were designed to
amplify the DNA sequence and the PCR products were cloned
into the pET-24a (+) vector (Novagen) and expressed in BL21-RIL
strain (Stratagene, California, USA). The fusion proteins were
purified using two-step purification method via Nickel colums
(Qiagen) according to manufacturer’s protocol.
Recombinant proteins were used for immunization of rabbits
and generation of polyclonal stevor antibodies. These latest have
been renamed as S1 and S2 antisera which were used for all
subsequent experiments.
Generation of P. falciparum clonal lines
Clonal lines of P. falciparum 3D7 parasites were isolated by
limiting dilution using 96-well microtitre plates as previously
described [39]. Positive wells were identified by Giemsa staining
over a period of 14 to 21 days after cloning. Different clones were
screened by immunofluorescence assay co-staining with anti-
PfSBP1 and either anti-S1 (Figure 2A) or –S2 (Figure 2B) sera.
Four clonal lines (5A, 5B, 3.2C and 5.2A) showing different
staining patterns against anti-S1 and –S2 (Figure 2A and 2B) sera
were further selected for subsequent experiments.
Immunofluorescence assays (IFA) of fixed parasite
preparations
Thin blood smears were prepared at different stages of highly
synchronized P. falciparum parasites through the erythrocytic life
cycle. Slides were fixed at 4uC in acetone for 5 min, wrapped in foil
and stored at 220uC. When required, slides were allowed to reach
room temperature, blocked with Diluent Buffer 2 (PBS/1%BSA/
0.05% sodium azide) and then incubated for 1 h in a humid
chamber with primary following antibodies: rabbit anti-S1 (1:200)
and –S2 (1:400) antibodies and mouse (B28) anti-P. falciparum
skeleton binding protein 1 (anti-PfSBP1) (1:200) (kind gift of
Catherine Braun-Breton). This was followed by secondary antibod-
ies:AlexaFluor488coupled anti-rabbit(1:200)andAlexaFluor594
coupled anti-mouse (1:200) antibodies (Molecular Probes). Slides
were then briefly dipped three times in 4,6-diaminido-2-phenylin-
dole (DAPI, 2 mg/mL in PBS) for parasite nuclei staining and
viewed under Olympus fluorescent microscope.
Western blotting
Schizonts of 44–48 hours from different cultures at 5%
parasitemia were enriched by Percoll as previously described [38].
Schizont extracts or uninfected RBCs were fractionated into three
protein populations: soluble proteins (S), carbonate-peripherally
membrane-associated proteins (C), and pellet-integral-membrane
proteins (P) by sequential protein extraction as previously described
[40]. Different fractions were then separated by Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred onto nitrocellulose membrane. To detect STEVOR proteins,
membrane were probed with rabbit anti-S1 and anti-S2 polyclonal
sera diluted in PBS/0.05%Tween at 1:5000 and 1:1000 respective-
ly, followed by the respective horseradish peroxidase (HRP)-
conjugated secondary antibody enhanced by SuperSignal West
Pico Chemiluminescent Substrate (PIERCE) according to manu-
facturer’s recommendations. Anti-glycophorin C (Ret40f) antibody
purchased from V-Cell Science (Santa Cruz Biotechnology) was
used as loading control to ensure that same amount of protein from
membrane fraction was loaded in each lane.
Agglutination assay
P. falciparum trophozoites-iRBCs (,5% parasitemia) were
synchronized by purification by Percoll gradient as previously
described [38]. Fresh uninfected erythrocytes were added to
ensure that the parasitemia of pigmented trophozoites was around
5%. Cells were diluted to 5% heamatocrit in PBS containing
ethidium bromide (10 mg/ml) (Sigma). 22.5 ml of parasites
suspension were added to 2.5 ml either anti-S1 or -S2 serum (final
dilution 1/10) or pre-immune serum in 1.5 ml Eppendorf tubes.
Samples were incubated at room temperature for 45 min on a
rotating wheel (30 rpm). Following gentle resuspension, 10 mlo f
cells suspension was gently smeared in a circular motion with a
plastic micropipette tip onto glass slides as previously described
[41]. Duplicate 1.5 cm diameter smears were made, air-dried for
5 min, fixed in methanol and stained for 10 min with 10%
Giemsa’s stain. Smears were then preserved with mounting
medium and a glass cover slip. Samples were examinated by light
microscopy and classified as positive by agglutination if they
contain $3 agglutinates of intact iRBCs. Size of agglutinates were
quantified as follows: size A, 3 to 5 cells; size B, 6 to 10 cells; size C,
.10 cells.
Live immunofluorescence assay and flow cytometry
analysis of the iRBC surface
Live immunofluorescence assay (Protocol S1) was performed on
parasites when the majority were ideally in late schizont stage.
IRBCs were pelleted from culture by centrifugation at 8006g for
3 minutes, washed thrice with RPMI 1640 w/o albumax.
Parasitemia was diluted to 5% with uninfected erythrocytes and
parasites were resuspended at 5% heamatocrit. Fifty ml of cells
suspension containing either anti-S1, -S2 rabbit sera or ant-SBP1
mouse serum at different dilutions (1:10–1:400) were incubated for
1 h at room temperature, following which the cells were re-
suspended in 50 ml of secondary anti-mouse or rabbit IgG
antibody at the appropriate dilution in RPMI 1640 containing
ethidium bromide (1 mg/ml). Following 1 h incubation, a drop of
cells was placed onto a glass slide, mixed with 10 ml mounting
medium, then cell surface staining was visualized with a Olympus
fluorescence microscope at 1006magnification.
For flow cytometry analysis, RPMI 1640 was replaced by PBS
containing 0.1% BSA. Cells (10.000) were counted on a FACs
Calibur using Cell Quest software (Becton Dickinson, San Jose,
CA, USA). Gates were set using either iRBCs only or stained with
alexa fluor secondary antibody. The amount of IgG bound
antigens on the erythrocyte surface was then measured as the
mean fluorescence signal. The different parasites staining were
visualized in dot plots as fluorescence in FL1 channel.
Permeabilization of iRBCs with pore-forming Streptolysin
O
Streptolysin O (SLO) was purchased from Sigma Chemical Co
(St. Louis, MO, U.S.A.) and prepared by method that allows post-
activation storage as previously described [42]. Briefly, SLO
(25 000 units) was re-suspended in 1 ml of PBS and aliquots were
stored at 220uC. Prior to use, SLO aliquots were thawed at room
temperature and activated by incubation with 100 mM dithio-
threitol for 15 min. For permeabilization, 2610
8 iRBCs were
resuspended in 200 ml of buffer (1XPBS/1% BSA) containing 3–4
heamolytic units of SLO as defined previously [43] and incubated
at room temperature for 6 min. Cells were pelleted at 8506g for
5 min and washed twice with PBS/1%BSA. The pellet (permea-
bilized iRBCs) was analyzed by live immunofluorescence and
FACS analysis (as described above) for specific PfSBP1 staining.
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Intact iRBCs were pelleted and resuspended in trypsin (Sigma
Chemical) solution (1 mg/ml in RPMI 1640 w/o albumax) for
5 min at 37uC with constant rotation. The reaction was stopped
by addition of trypsin inhibitor (Sigma Chemical) (1 mg/ml) for
another 5 min. Cells were washed with RPMI 1640 w/o albumax
or PBS and resuspended in PBS.
Microarray analysis
RNA obtained from different time points of synchronized P.
falciparum intracellular blood-stage parasites of 5A, 3.2C, 5.2A and
5B clones were hybridized against a reference pool from the same
clone as previously described [44] using a P. falciparum long
oligonucleotide microarray [45]. Microarray analysis, data
acquisition and analysis were performed (Protocol S1) as recently
described [25].
Supporting Information
Protocol S1 Supplemental materials and methods
Found at: doi:10.1371/journal.ppat.1000307.s001 (0.03 MB
DOC)
Table S1 Transcriptional analysis of stevor gene family in the
different clones. Summary of microarray analysis of transcribed
stevor genes during asexual blood stage from 24 hrs after invasion
and onward in the four clones. Relative transcription levels of 34
stevor genes are shown. Analysis was performed as described in the
Materials and Methods section. Bold P+ denotes highly tran-
scribed genes, P- denotes low transcription, and ND denotes
nondetected genes. Genes are shown by their accession numbers.
Found at: doi:10.1371/journal.ppat.1000307.s002 (0.06 MB XLS)
Table S2 Specific primers sets used to amplify the 6 stevor genes
and the seryl-tRNA synthetase housekeeping gene
Found at: doi:10.1371/journal.ppat.1000307.s003 (0.21 MB TIF)
Figure S1 Transcriptional levels of selected stevor genes in the
four clones. Analysis of the stevor gene was performed at 24–
28 hours post-invasion for the four clones. Hatched grey bar
represents level of transcription of the seryl-tRNA synthetase
housekeeping gene.
Found at: doi:10.1371/journal.ppat.1000307.s004 (0.22 MB TIF)
Figure S2 Indirect immunofluorescence assay (IFA) of asexual
stages of the 5A clone. Immunofluorescence staining of mature
(.24 hour) blood-stage P. falciparum parasites using anti-S1 (A) and
anti-S2 sera (B). Staining of trophozoite (T) and late schizont (LS)
stage parasites are shown. Parasites’ proteins were stained with
anti-S1 or -S2 rabbit serum (green), the Maurer’s cleft-specific
anti-PfSBP1 mouse serum (red). Parasites’ nuclei were stained with
DAPI (2 mg/ml) (blue). The individual stains as well as the merged
(S1/S2+SBP1, merge) images are shown. BF denotes bright field
image.
Found at: doi:10.1371/journal.ppat.1000307.s005 (1.02 MB TIF)
Figure S3 Timing of STEVOR surface expression
Found at: doi:10.1371/journal.ppat.1000307.s006 (0.21 MB TIF)
Figure S4 Agglutination assays
Found at: doi:10.1371/journal.ppat.1000307.s007 (0.59 MB TIF)
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